Investigators evaluated overall participation and equity across socioeconomic groups in a population wide colorectal cancer screening program in Hong Kong.

Noninvasive surveillance with multitarget stool DNA testing or fecal immunochemical testing (FIT) could potentially match colonoscopy for reducing long-term colorectal cancer (CRC) incidence and ...

With a short percentage of shares outstanding of 2.76%, IDEXX Laboratories, Inc. (NASDAQ:IDXX) is among the 7 Best Pet Care Stocks to Buy for Consistent Recurring Revenue. On May 26, IDEXX ...

Current US FDA-cleared stool-based colorectal cancer (CRC) molecular screening tests include fecal immunochemical tests (FIT) for occult blood detection; however, integration with nucleic acid-based ...

At-home microbiome tests are having a moment. You mail in a stool sample and get back a report on your gut bacteria, along ...

Routine screening with fecal occult blood testing (FOBT) is associated with a decrease in colorectal cancer (CRC) mortality, according to a study published online Feb. 27 in JAMA Network Open.

Annual fecal immunochemical test-based surveillance could be as effective as colonoscopies in reducing long-term colorectal cancer incidence and mortality, according to a recent study published in ...

WESTBROOK, Maine, Jan. 12, 2024 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, announced the expansion of its Fecal Dx® antigen testing platform ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Everyone's mailing in stool samples for a gut report, but can an at-home microbiome test actually tell you anything?